AG0302-COVID19 High-dose

· AnGes, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AG0302-COVID19 High-dose, covering 2022-11-09 to 2022-11-09. Get the full timeline:

Most recent: Clinical Trial Update: Phase I/II Study of COVID-19 DNA Vaccine (AG0302-COVID19 High-dose) [Phase 1, Phase 2]